Glycoprotein Peptide
-
- Target
- Glycoprotein
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequence
- DGENGTGQSH HNVFPDGKPF PHHPGWRRWN FIYVFHTLGQ YFQKLGRCSV
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GPNMB antibody,
Alternative Names: Glycoprotein control peptide, Glycoprotein antibody Blocking Peptide, Anti-Glycoprotein Blocking Peptide, HGFIN Blocking Peptide, NMB Blocking Peptide, Transmembrane Nmb Blocking Peptide, GPNMB Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Glycoprotein
- Synonyms
- glycoprotein Peptide, Glycoprotein Peptide, transmembrane glycoprotein G Peptide, G Peptide, RVFV_sM_gp1 Peptide, RABVgp4 Peptide
- Target Type
- Viral Protein
- Background
- GPNMB is a type I transmembrane glycoprotein which shows homology to the pMEL17 precursor, a melanocyte-specific protein. GPNMB shows expression in the lowly metastatic human melanoma cell lines and xenografts.
- Molecular Weight
- 62 kDa
-